Intercure annual operating income
2019
2020
2021
2022
2023
2024
2025
Intercure Operating Income Growth & History (INCR)
Intercure's operating income was ₪6.7M for fiscal 2025.
View full Intercure company overviewIntercure annual operating income history
| Fiscal year | Period ended | Operating income | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | ₪6.7M | ₪73.9M | — |
| 2024 | 2024-12-31 | −₪67.2M | −₪25.6M | — |
| 2023 | 2023-12-31 | −₪41.6M | −₪92.2M | — |
| 2022 | 2022-12-31 | ₪50.6M | ₪22.4M | +79.62% |
| 2021 | 2021-12-31 | ₪28.2M | ₪66.6M | — |
| 2020 | 2020-12-31 | −₪38.4M | −₪35.0M | — |
| 2019 | 2019-12-31 | −₪3.4M | — | — |
Intercure operating income trends
Over the last five fiscal years, Intercure's operating income increased from −₪38.4M to ₪6.7M, a change of ₪45.1M.
About the metric
What operating income means
Operating income is the profit or loss a company generates from its core business after cost of revenue and operating expenses, but before non-operating items such as interest and income taxes.
Calculation and source
SEC-reported operating income
TickerStat standardizes operating income reported in company SEC filings for aligned fiscal periods. It is not adjusted EBIT, an analyst estimate, or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Intercure source filings ↗Community posts
InterCure resolves Nasdaq minimum-bid-price deficiency
InterCure ($INCR) received written confirmation that it has regained compliance with Nasdaq’s minimum-bid-price requirement. Its shares had closed at or above $1 for ten consecutive business days, allowing Nasdaq to close the specific defic ...